Company Overview
iSonea technology offers immense advantages with respect to the capture, storage and analysis of respiratory sounds objectively and without relying on patient cooperation.
iSonea is dedicated to providing a full range of products, all based on its core technology, but implemented in the configuration that is most appropriate for its use – from a patient’s home to the Intensive Care Unit.
iSonea Ltd is a joining of two sector leaders, each with a unique proprietary respiratory acoustic technology:
- iSonea (Israel): Passive technology; an ingenious technique to listen and analyze the lung acoustics generated during the respiratory cycle.
- Pulmosonix (Australia): Active technology that focuses on injecting sounds into the thorax and picking the changed signal at various locations, reaching diagnostic conclusions from the sound propagation data.
The synergy between the technologies and the ability to combine the two approaches, allows iSonea to offer solutions no other market player can tackle. It resolves clinical challenges previously deemed impossible.
iSonea is proud to present its latest products and services:
 |
An excellent choice for asthma monitoring and for patients who cannot perform spirometry; such as small children, elderly and acute asthmatics. |
 |
WHolter® A 24-hours wheezing and cough recorder in the patient’s own allergen environment and for evaluation of Nocturnal Asthma. |
|
A home use personal novel device provides the patient with real online information as to his Wheeze rate situation. |
|
ASAM, Acoustic Severe Asthma Monitor Technology aimed at the emergency medicine and intensive care units, focusing on injecting sounds into the thorax and picking up the changed signal at various locations, reaching diagnostic conclusions from the sound propagation data. |
|
The iSonea technology offers immense advantages with respect to the capture, storage and analysis of respiratory sounds objectively and without relying on patient cooperation.
iSonea is dedicated to providing a full range of products, all based on its core technology but implemented in the configuration that is most appropriate for its use – from the patient’s home to the Intensive Care Unit.
